Anti-angiogenic agent-associated adrenal insufficiency in immune checkpoint inhibitors-treated patients

被引：3
|
作者：
Guo, Qixiang [1 ]
Lu, Wenchao [1 ]
Sun, Ximu [2 ]
Zhao, Zhixia [1 ]
Liu, Lihong [3 ]
机构：
[1] Capital Med Univ, Beijing Chaoyang Hosp, Dept Pharm, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Obstet & Gynecol Hosp, Dept Pharm, Beijing, Peoples R China
[3] China Japan Friendship Hosp, Dept Pharm, Beijing, Peoples R China
来源：
EUROPEAN JOURNAL OF CANCER | 2021年 / 157卷
关键词：
D O I：
10.1016/j.ejca.2021.08.038
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：358 / 360
页数：3
相关论文
共 50 条
  • [41] Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
    Mahmood, Syed S.
    Fradley, Michael G.
    Cohen, Justine V.
    Nohria, Anju
    Reynolds, Kerry L.
    Heinzerling, Lucie M.
    Sullivan, Ryan J.
    Damrongwatanasuk, Rongras
    Chen, Carol L.
    Gupta, Dipti
    Kirchberger, Michael C.
    Awadalla, Magid
    Hassan, Malek Z. O.
    Moslehi, Javid J.
    Shah, Sachin P.
    Ganatra, Sarju
    Thavendiranathan, Paaladinesh
    Lawrence, Donald P.
    Groarke, John D.
    Neilan, Tomas G.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (16) : 1755 - 1764
  • [42] Immune checkpoint inhibitor-associated adrenal insufficiency in Chinese cancer patients: a retrospective analysis
    Qingqing Cai
    Wei Wu
    Xiaoyu Li
    Qing Xu
    Lin Zhao
    Qianzhou Lv
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 14113 - 14123
  • [43] Immune checkpoint inhibitor-associated adrenal insufficiency in Chinese cancer patients: a retrospective analysis
    Cai, Qingqing
    Wu, Wei
    Li, Xiaoyu
    Xu, Qing
    Zhao, Lin
    Lv, Qianzhou
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (15) : 14113 - 14123
  • [44] Hypertension in cancer patients treated with anti-angiogenic based regimens
    Wasserstrum Y.
    Kornowski R.
    Raanani P.
    Leader A.
    Pasvolsky O.
    Iakobishvili Z.
    Cardio-Oncology, 1 (1)
  • [45] Treatment-related adverse events of combined anti-angiogenic and immune checkpoint inhibitors: systematic review and meta-analysis
    Lian Chen
    Ling Wu
    Zhang Lu
    Qin Huang
    Liu Huang
    OncologyandTranslationalMedicine, 2022, 8 (06) : 301 - 310
  • [46] Combination of Immune Checkpoint Inhibitors and Anti-Angiogenic Agents in Brain Metastases From Non-Small Cell Lung Cancer
    Fang, Likui
    Zhao, Wuchen
    Ye, Bo
    Chen, Da
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [47] Incidence and relative risk of hepatic toxicity in patients treated with anti-angiogenic tyrosine kinase inhibitors for malignancy
    Iacovelli, Roberto
    Palazzo, Antonella
    Procopio, Giuseppe
    Santoni, Matteo
    Trenta, Patrizia
    De Benedetto, Angelina
    Mezi, Silvia
    Cortesi, Enrico
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 77 (06) : 929 - 938
  • [48] Morphology of immune-mediated hepatitis: A comparison between immune checkpoint inhibitor therapy and combined immune checkpoint inhibitor/anti-angiogenic therapy
    Zhang, Qiongyan
    Chen, Lingli
    Guo, Xinxin
    Shen, Licheng
    Huang, Yufeng
    Chen, Yi
    Zhang, Ningping
    Ge, Ningling
    Gao, Hong
    Zhang, Wen
    Hou, Yingyong
    Ji, Yuan
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2024, 68
  • [49] Immune checkpoint inhibitors and adrenal insufficiency: a large-sample case series study
    Cui, Kai
    Wang, Ziqi
    Zhang, Qianqian
    Zhang, Xiaoju
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (05)
  • [50] Primary adrenal insufficiency induced by immune checkpoint inhibitors: biological, clinical, and radiological aspects
    Martella, Serafina
    Lucas, Minke
    Porcu, Michele
    Perra, Laura
    Denaro, Nerina
    Pretta, Andrea
    Deias, Giulia
    Willard-Gallo, Karen
    Parra, Hector Soto
    Saba, Luca
    Scartozzi, Mario
    Wekking, Demi
    Kok, Marleen
    Aiello, Marco Maria
    Solinas, Cinzia
    SEMINARS IN ONCOLOGY, 2023, 50 (06) : 144 - 148
12345